Skip to main content
BTC / USDT———ETH / USDT———SOL / USDT———BNB / USDT———XRP / USDT———DOGE / USDT———TON / USDT———AVAX / USDT———LINK / USDT———ADA / USDT———TRX / USDT———DOT / USDT———BTC / USDT———ETH / USDT———SOL / USDT———BNB / USDT———XRP / USDT———DOGE / USDT———TON / USDT———AVAX / USDT———LINK / USDT———ADA / USDT———TRX / USDT———DOT / USDT———
Visualize
Charts12 chart types: candlestick, Renko, P&F, deltaIndicators123 built-in, Barometer, no marketplaceDrawing tools82 tools: Fibonacci, Gann, Elliott, harmonicsPatterns59 candle, 19 chart and 9 harmonic patterns, auto-detected
Screen & automate
ScannerMulti-timeframe screening, 140 rulesStrategyBacktest with slippage and commissions, 40 presetsAuto-tradingWebhook, signal, DCA and grid bots
Build & practice
Any Script Converter6 languages, one clickPaper trading$10K virtual account, zero riskModules9 professional analysis modules
Open the terminal Multi-pane chart workspace. No install, free paper account.
How TW coins worksEarn TW coins for lessons, ideas, broker reviews and a daily habitLeaderboardWeekly traders ranking, resets every MondayLearn tradingLessons, quizzes and rewards TW coinsTW coinA loyalty score inside the product: earned for lessons, ideas and a daily habit. TW Coins are not money and cannot be bought, transferred or withdrawn.
Best BrokersCompare regulated forex, crypto, and stock brokers based on TW Score, regulatory status, and trader reviews.Brokers NewsCompany announcements and press releasesFind my brokerAnswer a few questions and see the brokersCompare brokersPick up to 4 brokers and compare themTrading calculatorsWork out pip value, position size and marginBroker regulatorsFinancial regulators grouped by grade and jurisdiction, and the brokers licensed by each
DocsConcepts and referenceIdeasLatest from the communityJournalLongreads, analytical articlesResearchMethod breakdowns on historical chartsProduct UpdatesNew features, releases and platform updatesWeb3 toolsLaunch and manage tokens without code
Pricing
Get started→
stocksAug 10, 2026, 9:43 PM

Hims & Hers Health Testing Peptide Ingredients Ahead of Potential FDA Decision on Compounding

Hims & Hers Health announced on its earnings call that it is testing peptide ingredients such as BPC-157, while also noting that gross margins will remain below historical levels due to international and weight-loss business expansion, and AI will help lower subscriber prices in 2026.

HIMS
  • Testing peptide ingredients including BPC-157 ahead of an expected FDA decision on whether to allow compounding for the drugs.
  • Gross margins expected to stay below historical levels, driven by international and weight-loss business expansion.
  • An executive said AI technology will help lower prices for weight-loss subscribers in 2026.

Source: First Squawk